Inventor · disambiguated record
Neil Josephson
Also filed as: JOSEPHSON NEIL · JOSEPHSON NEIL C · JOSEPHSON NEIL CARY
7 granted patents·6 pending applications·9 citations·filing 2010–2025
76Inventor score
Files withBIOVERATIV THERAPEUTICS INC3SEAGEN INC3BRISTOL MYERS SQUIBB CO2ZYMEWORKS BC INC2IAMBIC THERAPEUTICS INC1
Top patents by PatentIndex Score
13 records- 0190US11286528B2Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapyBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Mar 29, 2022·4 cites·14 claims
- 0282US10221455B2Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapyBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted Mar 5, 2019·5 cites·25 claims
- 0375US12371747B2Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapyBIOVERATIV THERAPEUTICS INC·Filed 2022·Granted Jul 29, 2025·0 cites·17 claims
- 0466US2024245753A1Methods of reducing side effects of anti-cd30 antibody drug conjugate therapySEAGEN INC·Filed 2023·Application pending·0 cites
- 0564US12435157B2Methods of using a bispecific antigen-binding construct targeting HER2 for the treatment of biliary tract cancersZYMEWORKS BC INC·Filed 2021·Granted Oct 7, 2025·0 cites·26 claims
- 0661US2022298243A1Anti-pd-1 antibody in combination with an anti-cd30 antibody in cancer treatmentBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0755US11299543B2Use of an anti-PD-1 antibody in combination with an anti-CD30 antibody in cancer treatmentBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 12, 2022·0 cites·10 claims
- 0854US2025136714A1Methods of treating cancer with anti-her2 biparatopic antibodiesZYMEWORKS BC INC·Filed 2022·Application pending·0 cites
- 0953US2022226439A1Methods of reducing side effects of anti-cd30 antibody drug conjugate therapySEAGEN INC·Filed 2018·Application pending·0 cites
- 1048US11795229B2Methods of reducing side effects of anti-CD30 antibody drug conjugate therapySEAGEN INC·Filed 2018·Granted Oct 24, 2023·0 cites·20 claims
- 1147US2020102399A1Methods of Treating Peripheral T Cell Lymphoma Using Anti-CD30 Antibody Drug Conjugate TherapySEATTLE GENETICS INC·Filed 2019·Application pending·0 cites
- 1242US8691211B2Suppression of immune response to factor VIII in hemophilia A patientsJOSEPHSON NEIL CARY·Filed 2010·Granted Apr 8, 2014·0 cites·26 claims
- 1336US2025345339A1Doses and regimens of her2 inhibitorsIAMBIC THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Neil Josephson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →